Therapeutic Classification

thiazolidinedione Registry

Clinical reference for thiazolidinedione medications. Access safety monographs, dosing adjustments, and drug-drug interactions for all registered brand names and generics in this class.

Registered Medications (thiazolidinedione)

Medication	Therapeutic Class	Maternal Safety
PIOGLITAZONE Strong CYP2C8 inhibitors may increase levels Can cause or exacerbate congestive heart failure and bladder cancer.	Thiazolidinedione	safe
PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE Strong CYP2C8 inhibitors may increase levels Can cause or exacerbate congestive heart failure and bladder cancer.	Thiazolidinedione	safe
PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE Strong CYP2C8 inhibitors may increase levels Can cause or exacerbate congestive heart failure and bladder cancer.	Thiazolidinedione	safe
ROSIGLITAZONE Strong CYP2C8 inhibitors may increase levels Can cause or exacerbate congestive heart failure and myocardial ischemia.	Thiazolidinedione	safe
ROSIGLITAZONE MALEATE Strong CYP2C8 inhibitors may increase levels Can cause or exacerbate congestive heart failure and myocardial ischemia.	Thiazolidinedione	safe
ROSIGLITAZONE MALEATE AND GLIMEPIRIDE Strong CYP2C8 inhibitors may increase levels Can cause or exacerbate congestive heart failure and myocardial ischemia.	Thiazolidinedione	safe
ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE Strong CYP2C8 inhibitors may increase levels Can cause or exacerbate congestive heart failure and myocardial ischemia.	Thiazolidinedione	safe

This therapeutic registry is dynamically synthesized from professional clinical sources. Listing of a medication does not imply equivalence; refer to individual monographs for head-to-head pharmacological data.